Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer
{{output}}
Introduction: EphB4, a receptor tyrosine kinase, is a known promoter of tumor growth and a promising therapeutic target for cancer therapies. However, its contribution to the development and treatment of lung cancer (LC) is not c... ...
